Telpegfilgrastim for chemotherapy-induced neutropenia in breast cancer: A multicenter, randomized, phase 3 study

• Yuankai Shi,
• Qingyuan Zhang,
• Junsheng Wang,
• Zhong Ouyang,
• Tienan Yi,
• Jiazhuan Mei,
• Xinshuai Wang,
• Zhidong Pei,
• Tao Sun,
• Junheng Bai,
• Shundong Cang,
• Yarong Li,
• Guohong Fu,
• Tianjiang Ma,
• Huaqiu Shi,
• Jinping Liu,
• Xiaojia Wang,
• Hongrui Niu,
• Yanzhen Guo,
• Shengyu Zhou,
• Li Sun,
• Yanjie Yin

Affiliations

Yuankai Shi

1 Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China

Qingyuan Zhang

2 Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150000, China

Junsheng Wang

3 Department of Oncology, Anyang Cancer Hospital, Anyang, Henan 455000, China

Zhong Ouyang

4 Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, China

Tienan Yi

5 Department of Oncology, Xiangyang Central Hospital, Xiangyang, Hubei 441000, China

Jiazhuan Mei

6 Department of Oncology, Zhengzhou People’s Hospital, Zhengzhou, Henan 450000, China

Xinshuai Wang

7 Department of Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471000, China

Zhidong Pei

8 Department of Oncology, Luoyang Central Hospital, Luoyang, Henan 471000, China

Tao Sun

9 Department of Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital, Shenyang, Liaoning 110000, China

Junheng Bai

10 Department of Breast, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, China

Shundong Cang

11 Department of Oncology, Henan Provincial People’s Hospital, Zhengzhou, Henan 450000, China

Yarong Li

12 Department of Oncology & Hematology, The Second Hospital of Jilin University, Changchun, Jilin 130000, China

Guohong Fu

13 Department of General Surgery, Sanya Central Hospital (Hainan Third People’s Hospital), Sanya, Hainan 572000, China

Tianjiang Ma

14 Department of Oncology, Luohe Central Hospital, Luohe, Henan 462000, China

Huaqiu Shi

15 Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, China

Jinping Liu

16 Department of Galactophore Surgery, Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610000, China

Xiaojia Wang

17 Department of Breast Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310000, China

Hongrui Niu

18 Department of Oncology, The First Affiliated Hospital of Xinxiang Medial University, Xinxiang, Henan 453000, China

Yanzhen Guo

7 Department of Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471000, China

Shengyu Zhou

1 Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China

Li Sun

19 Xiamen Amoytop Biotech Co., LTD, Xiamen, Fujian 361000, China

Yanjie Yin